Aspiriant Holdings S3’s Thermo Fisher Scientific TMO Stock Holding History

Aspiriant Holdings S3’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2M	Sell	14,071 -315	-2%	-$42K	0.86%	44
2015 Q3	$1.76M	Buy	14,386 +178	+1%	+$23.2K	0.81%	46
2015 Q2	$1.84M	Sell	14,208 -219	-2%	-$28.6K	0.74%	52
2015 Q1	$1.94M	Sell	14,427 -135	-0.9%	-$17.4K	0.77%	47
2014 Q4	$1.82M	Sell	14,562 -120	-0.8%	-$14.6K	0.75%	49
2014 Q3	$1.79M	Sell	14,682 -464	-3%	-$56.4K	0.72%	47
2014 Q2	$1.79M	Sell	15,146 -4	-0%	-$471	0.71%	48
2014 Q1	$1.82M	Buy	+15,150	New	+$1.8M	0.77%	46

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aspiriant Holdings S3's TMO Position: Q4 2015 in Review

Aspiriant Holdings S3 reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q4 2015, selling an estimated $42K and leaving 14,071 shares worth $2M. The position accounts for 0.86% of the portfolio, ranked #44.

Aspiriant Holdings S3 first reported a position in TMO in Q1 2014 and has held it in 8 quarters since. 1,006 funds tracked by Wall St. Rank hold TMO as of Q4 2015.

Aspiriant Holdings S3 held 14,071 shares of Thermo Fisher Scientific worth $2M as of Q4 2015.
Aspiriant Holdings S3 sold 315 Thermo Fisher Scientific shares in Q4 2015, an estimated $42K.
Thermo Fisher Scientific made up 0.86% of Aspiriant Holdings S3's portfolio in Q4 2015, its #44 holding.
Aspiriant Holdings S3 first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 8 quarters since.
1,006 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.